Case studies in cost effectiveness of molecular diagnostics for infectious diseases: Pulmonary tuberculosis, enteroviral meningitis, and BK virus nephropathy

Clinical Infectious Diseases

Volumn 43, Issue 11, 2006, Pages 1463-1467

  Nolte, Frederick S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL GENETICS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BK VIRUS; CLINICAL LABORATORY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ENTEROVIRUS INFECTION; FOOD AND DRUG ADMINISTRATION; GENE AMPLIFICATION; GENE MUTATION; GENE TECHNOLOGY; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; LUNG TUBERCULOSIS; MOLECULAR GENETICS; NUCLEIC ACID AMPLIFICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; VIRAL GENETICS; VIRUS CULTURE; VIRUS DIAGNOSIS; VIRUS MENINGITIS;

BK VIRUS; COST-BENEFIT ANALYSIS; ENTEROVIRUS INFECTIONS; HUMANS; KIDNEY DISEASES; MENINGITIS, VIRAL; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY; TUMOR VIRUS INFECTIONS;

EID: 33751572165     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508871     Document Type: Review

References (16)

1. Piersimoni C, Scarparo C. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microhiol 2003; 41:5355-65.
2. Dowdy DW, Maters A, Parrish N, et al. Cost-effectiveness analysis of the Gen-Probe amplified Mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. J Clin Microbiol 2003; 41:948-53.
3. Mazurek G, Daniels L, LoBue P, et al. Clinical and economic impact of nucleic acid amplification tests (NAAT) on the diagnosis of tuberculosis (TB) (abstract A95). In: Program and abstracts of the 106th American Thoracic Society International Conference (San Diego). New York; American Thoracic Society, 2005:A272.
4. Sawyer MH. Enterovirus infections: diagnosis and treatment. Curr Opin Pediatr 2001; 13:65-9.
5. Marshall GS, Hauck MA, Buck G, et al. Potential cost savings through rapid diagnosis of enteroviral meningitis. Pediatr Infect Dis J 1997; 16:1086-7.
6. Hamilton MS, Jackson MA, Abel D. Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr Infect Dis J 1999; 18:533-7.
7. Ramers C, Billman G, Hartin M, et al. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 2000; 283:2680-5.
8. Nigrovic LE, Chiang VW. Cost analysis of enteroviral polymerase chain reaction in infants with fever and cerebrospinal fluid pleocytosis. Arch Pediatr Adolesc Med 2000; 154:817-21.
9. Robinson CC, Willis M, Meagher A, et al. Impact of rapid polymerase chain reaction results on management of pediatric patients with enteroviral meningitis. Pediatr Infect Dis J 2002; 21:283-6.
10. Stellrecht KA, Harding I, Woron AM, et al. The impact of an enteroviral RT-PCR assay on the diagnosis of aseptic meningitis and patient management. J Clin Virol 2002; 25(Suppl 1):S19-26.
11. Kost C, Rogers H, Oberste S, et al. A multi-center beta trial of the GeneXpert enterovirus assay (abstract C-292). In: Program and abstracts of the 106th General Meeting of the American Society for Microbiology (Orlando, FL). Washington, DC: American Society for Microbiology, 2006:159.
12. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347:488-96.
13. Bressollette-Bodin C, Coste-Burel M, Hourmant M, et al. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 2005; 5:1926-33.
14. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342:1309-15.
15. Randhawa P, Ho A, Shapiro R, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004; 42:1176-80.
16. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79:1277-86.